Page last updated: 2024-12-06
iodecol
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Cross-References
ID Source | ID |
---|---|
PubMed CID | 71247 |
CHEMBL ID | 2104392 |
SCHEMBL ID | 380986 |
MeSH ID | M0117253 |
Synonyms (13)
Synonym |
---|
iodecimol |
5-[[3-[3,5-bis(1,3-dihydroxypropan-2-ylcarbamoyl)-n-(2-hydroxyethyl)-2,4,6-triiodoanilino]-3-oxopropanoyl]-(2-hydroxyethyl)amino]-1-n,3-n-bis(1,3-dihydroxypropan-2-yl)-2,4,6-triiodobenzene-1,3-dicarboxamide |
81045-33-2 |
iodecimol [inn-latin] |
iodecimol [inn] |
iodecol |
5,5'-(malonylbis((2-hydroxyethyl)imino))bis(n,n'-bis(2-hydroxy-1-(hydroxymethyl)ethyl)-2,4,6-triiodoisophthalamide) |
unii-3sdg4rsp99 |
3sdg4rsp99 , |
CHEMBL2104392 |
DTXSID50230870 |
SCHEMBL380986 |
Q27257977 |
Research Excerpts
Actions
Excerpt | Reference | Relevance |
---|---|---|
"Iodecol caused less increase of peak velocity of pressure rise and systolic blood pressure than Iopamidol." | ( [Acute cardiac side effects of iodecol, a new nonionic dimer roentgen contrast medium, in intracoronary injection]. Hellige, G; Hoeft, A; Hoeft, T; Kober, G; Korb, H; Schräder, R; Wolpers, HG, 1985) | 1.28 |
Toxicity
Excerpt | Reference | Relevance |
---|---|---|
"Selective vertebral angiography was performed in 28 rabbits in order to compare the adverse effects of two monomeric (metrizamide, iohexol) and two dimeric (iodecol, 2-5410-3) non-ionic water-soluble contrast media." | ( The toxicity of non-ionic water-soluble contrast media in selective vertebral angiography. An experimental study in rabbits with special reference to the difference between monomeric and dimeric compounds. Aulie, A; Skalpe, IO, 1985) | 0.47 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (4)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 4 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.66
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.66) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |